Elan Corporation Plc Newswire

Elan Corporation Plc Newswire

Comprehensive Real-Time News Feed for Elan Corporation Plc.

Results 1 - 20 of 20 in Elan Corporation Plc

  1. Who's who of rich investors eye a 100m Tallaght planRead the original story w/Photo

    Thursday May 21 | Independent.ie

    Firms linked to property development firm Davy Hickey have joined forces with some of Ireland's richest people in plans for a major Dublin 400-unit housing scheme in Tallaght that's likely to cost in the region of a 100m to build. But it will be just the first phase of a massive development that's being planned on lands controlled by the investors.

    Comment?

  2. Cambridge News published Cambridge's Kymab raises $50m to complete $90m funding roundRead the original story w/Photo

    Wednesday May 6 | Cambridge Evening News

    The cash is being invested by Woodford Patient Capital Trust and Malin Corporation, and follows a $40m investment from the Wellcome Trust and the Bill & Melinda Gates Foundation. It will enable Kymab to maximize the potential of its Kymouse platform and advance its proprietary pipeline of first-in-class therapeutic human monoclonal antibodies in areas of significant unmet medical need.

    Comment?

  3. Berkshire Income Realty Announces Year End ResultsRead the original story

    Dec 31, 2013 | Business Wire

    Financial highlights for the year ended December 31, 2014 include: - Same Property Net Operating Income increased 5.3% for the year ended December 31, 2014 - Same Property NOI, a non-GAAP financial measure, increased as a result of growth in revenue for properties acquired or placed in service prior to January 1, 2013. The Same Property Portfolio had a total revenue increase of approximately 4.1% for the year ended December 31, 2014 compared to the same period a year ago, primarily driven by increase in average monthly rental rates from $1,266 to $1,308.

    Comment?

  4. Ultragenyx Pharmaceuticals Appoints To Board Of DirectorsRead the original story

    Apr 12, 2015 | BioSpace

    Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the appointment of Daniel G. Welch to the company's Board of Directors effective April 8, 2015. Mr. Welch, former Chairman and Chief Executive Officer of InterMune and current Executive Partner at Sofinnova Ventures, will serve as an independent director to Ultragenyx.

    Comment?

  5. Novan Secures $50 Million Private FinancingRead the original story

    Mar 29, 2015 | Venture Capital Access Online

    Novan Therapeutics, a clinical-stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that it has secured $50 million in an oversubscribed private financing. New investor Malin Corporation Plc.

    Comment?

  6. Novan Therapeutics Secures $50 Million Private Financing; Funds...Read the original story

    Mar 29, 2015 | BioSpace

    Funds Intended to Advance SB204 into Phase 3 Clinical Testing Company Expands Board with the Addition of Three Directors DURHAM, N.C.-- --Novan Therapeutics, a clinical-stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that it has secured $50 million in an oversubscribed private financing. New investor Malin Corporation Plc.

    Comment?

  7. Durham's acne drug developer raises $50M, partly from Jim GoodnightRead the original story w/Photo

    Mar 30, 2015 | Business Journal

    The financing comes from a group that includes new investor Malin Corporation in a fund backed partly by billionaire SAS founder Jim Goodnight and brings new board members G. Kelly Martin , former CEO of Elan Corp. , and Sean Murphy , former head of M&A and business development for Abbott Laboratories , to help oversee the investment. "We believe the promise of Novan's pipeline and our advancement toward commercialization enabled us to attract strong participation in this round, leading us to close at twice the original target of $25 million," says Neal Hunter , Novan's founding investor and chairman.

    Comment?

  8. Dermatology drug firm Novan raises $50M in new financingRead the original story w/Photo

    Mar 30, 2015 | Local Tech Wire

    Novan Therapeutics, which is focused on development of new dermatology products, has closed on $50 million in new financing. The company lands a new investor and also adds two life science executives to its board.

    Comment?

  9. Novan Secures $50 Million Private FinancingRead the original story

    Mar 30, 2015 | Freshnews

    Novan Therapeutics, a clinical-stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that it has secured $50 million in an oversubscribed private financing. New investor Malin Corporation Plc.

    Comment?

  10. Panoz vs. Nissan Lawsuit Overshadows DeltaWing Road Car PlanRead the original story w/Photo

    Mar 23, 2015 | Automobile Magazine

    Dr. Donald Panoz was once described in print as a "portly redheaded entrepreneur," but a recent weight loss erased all signs of "portly," and age has replaced most of the red with silver. The slimming-down, he says, was done on purpose: He turned 80 in February, and figured it was time to start thinking of his health.

    Comment?

  11. North Wales Labour MPs stress the importance of better transport and...Read the original story w/Photo

    Mar 11, 2015 | IcNetwork

    North Wales Labour MPs stress the importance of better transport and communications for their region as they set out their priorities North Wales Labour MPs have pledged to push for a hub which will allow passengers from the region to connect to the planned HS2 rail service Connectivity is key to North Wales' future, according to Labour MPs who have put forward their vision for the region they will pursue if re-elected in May. The six North Wales Labour MPs are adamant that better mobile, broadband and transport services are needed if the area is to fulfil its potential. They have pledged to continue to press for a major rail hub at Crewe that will enable passengers from North Wales to connect to the planned High Speed 2 network.

    Comment?

  12. Building companies of scalea S-a SIsraeli entrepreneurs are in it for the long runRead the original story w/Photo

    Mar 9, 2015 | The Times of Israel

    Etan works as a digital marketer at OurCrowd, a global equity crowdfunding site focused on the Israeli early stage/startup scene, for accredited investors only. Etan is a startup enthusiast whose professional background includes managing luxury construction projects in NYC and founding a clothing company.

    Comment?

  13. Sofinnova Ventures taps former InterMune CEO as executive partnerRead the original story w/Photo

    Jan 8, 2015 | PE Hub

    Sofinnova Ventures, a Menlo Park based life science investment firm, announced today that Daniel G. Welch, former CEO of InterMune, has joined the Sofinnova team as an Executive Partner. Mr. Welch has a distinguished track record as a biotech executive, with over 30 years of experience across both multi-national pharmaceutical companies and biotech companies.

    Comment?

  14. Sofinnova Ventures Adds Daniel G. Welch to Life Science Investing TeamRead the original story w/Photo

    Jan 8, 2015 | Sys-Con Media

    Mr. Welch has a distinguished track record as a biotech executive, with over 30 years of experience across both multi-national pharmaceutical companies and biotech companies. Most recently, he was the Chairman, CEO and President of InterMune.

    Comment?

  15. How Dublin's Havok became a game-changer in a a 50bn industryRead the original story w/Photo

    Dec 3, 2014 | Independent.ie

    He may have an office like David Brent, but David Coghlan heads up one of Ireland's most successful ever home-grown tech companies One can lay claim to such an achievement. Look on the back of just about any major PlayStation or Xbox game release in shops this Christmas and you'll see one name written on each one: Havok.

    Comment?

  16. Prothena Corporation plc CEO Diagnosed With Pancreatic CancerRead the original story

    Dec 2, 2014 | BioSpace

    December 3, 2014 By Riley McDermid , BioSpace.com Breaking News Editor The chief executive of Prothena Corp has been diagnosed with pancreatic cancer and will be taking a limited role in the company until his treatment is completed, said President and Chief Executive Officer Dale Schenk this week. South San Francisco-based Prothena has been in the headlines lately as it starts a late-stage trial with its drug NEOD-001 as a possible treatment for a rare protein-misfolding heart and kidney disease.

    Comment?

  17. Horizon Pharma's (HZNP) CEO Timothy Walbert on Q3 2014 Results - Earnings Call TranscriptRead the original story w/Photo

    Nov 6, 2014 | Seeking Alpha

    Good morning, ladies and gentlemen, and welcome to the Horizon Pharma plc Third Quarter 2014 Earnings Call. [Operator Instructions] As a reminder, today's conference call is being recorded.

    Comment?

  18. Perrigo to buy Omega Pharma in $3.1-billion...Read the original story w/Photo

    Nov 6, 2014 | SFGate

    Perrigo is expanding its reach into Europe through a $3.1 billion acquisition of one of the continent's biggest suppliers of non-prescription medicines. Perrigo Co.

    Comment?

  19. Perrigo Expands Europe Reach With Omega Pharma DealRead the original story w/Photo

    Nov 6, 2014 | Investor's Business Daily

    Perrigo is expanding its reach into Europe through a $3.1 billion acquisition of one of the continent's biggest suppliers of non-prescription medicines. Perrigo Co.

    Comment?

  20. 'What If' - boringly monotonousRead the original story

    Oct 18, 2014 | Nerve News

    Set in Toronto, Wallace meets attractive animator Chantry whose boyfriend Ben is based in Dublin. Well, sparks don't fly instantly, but the underlying attraction is evident.

    Comment?